De la ville bleue à la métropole grise. Fondation, protection et destruction de Kökeqota (Huehaote)
Études mongoles et sibériennes, centrasiatiques et tibétaines · 2004
DOI: 10.3406/emong.2004.1150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Études mongoles et sibériennes, centrasiatiques et tibétaines, 2004. Verfasst von Isabelle Charleux. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
From the Blue City to the Grey Metropolis. Foundation, protection and destruction of Kökeqota (Huhehaote) Kökeqota, the “Blue City”, capital of the Inner Mongolia Autonomous Region in China, had preserved an architectural heritage of great richness until the 1990s. In 1987 it merited inclusion among the “nationally famous historic and cultural cities” of China. Yet, faced with strong demographic, economic, and urban expansion, the architectural heritage, although “protected”, suffers irreversible degradation. The old city, except for a few temples, is being razed. After a presentation of the city’s history, of its transformations during the Communist period, of the heritage policy, and in particular of the restoration of the religious structures, the article considers their state in 2002, evaluating the extent of the destruction and seeking to understand what is currently at stake.
Zitieren
APA
Charleux, I. (2004). De la ville bleue à la métropole grise. Fondation, protection et destruction de Kökeqota (Huehaote). Études mongoles et sibériennes, centrasiatiques et tibétaines. https://doi.org/10.3406/emong.2004.1150
Vancouver
Charleux I. De la ville bleue à la métropole grise. Fondation, protection et destruction de Kökeqota (Huehaote). Études mongoles et sibériennes, centrasiatiques et tibétaines. 2004. doi:10.3406/emong.2004.1150
BibTeX
@article{Charleux2004,
author = {Charleux, Isabelle},
title = {De la ville bleue à la métropole grise. Fondation, protection et destruction de Kökeqota (Huehaote)},
journal = {Études mongoles et sibériennes, centrasiatiques et tibétaines},
year = {2004},
doi = {10.3406/emong.2004.1150}
}
EUVIMED